Status:
ACTIVE_NOT_RECRUITING
Effects of Physical Exercise on Response to Treatement in Breast Cancer
Lead Sponsor:
Latvian Biomedical Research and Study Centre
Collaborating Sponsors:
Riga East Clinical University Hospital
Latvian Academy of Sport Education
Conditions:
Breast Cancer
Eligibility:
FEMALE
30-65 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to learn how regular physical exercise affects breast cancer patients' response to standard neoadjuvant chemotherapy (NAC) and to gain an insight into the molecular ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Primary breast cancer; stage IIA-B, IIIA-C (TNM: T1-4, N0-3, M0) at diagnosis
- Diagnosis established by core needle biopsy
- Age 30-65 years
- Prescribed doxorubicin/cyclophosphamide-based NAC
- Oral and written consent
- Exclusion criteria:
- Cardiac pathologies
- Pregnancy
- Blood transfusion in the last six months
- Another oncological disease
- Previous chemotherapy, hormonal or X-ray treatment
- Participation in another clinical trial
- Currently performing more than 180 min of moderate to high intensity aerobic training per week
Exclusion
Key Trial Info
Start Date :
August 16 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2027
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT06522971
Start Date
August 16 2022
End Date
December 30 2027
Last Update
September 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Latvian Biomedical Research and Study centre
Riga, Select One, Latvia, LV1067